Indeed, enhanced PI3K signaling due to amplification occurs in 10%–18% of high-grade serous ovarian carcinomas, which is the dominant histology of type II ovarian carcinoma [6,10,16]. Here, PIK3CA is linked to ovarian carcinoma.